Program List


Bring This Seminar to Your Hospital

OnSite and Host Site

BMTCN® Exam Review

Download .PDF Back to List

Course Description

This program is designed for transplant and cellular therapy oncology nurses preparing for the Oncology Nursing Certification Corporation BMTCN Exam. The review follows the 2022 BMTCN content outline. Concepts include foundations of transplant, transplant process and infusion, early and late transplant management and education, quality of life and professional performance. This is not an introductory program but a comprehensive review of TCT oncology practice.

Program Learning Outcomes

This program prepares the learner to:

  • Self-report at a 90% rate an increase in knowledge and test readiness in order to challenge the test and continue to provide optimum care for the transplant and cellular therapy patients.


Sign-in begins at 7:30 am. The day includes a one-hour lunch (on your own), as well as a morning and afternoon break of 15 minutes each. The order of lectures presented and break times may vary according to speaker preference. 

Day 1, 8:00 am to 4:30 pm

  • Eligibility Criteria for Initial Certification
    Application and Testing Process | Study Recourses | Test-Taking Tips
  • Basic Concepts for Transplantation
    Cell Lineage and Function | Immune System and Function | Goals of Therapy | Indication for Transplant
  • Types of Transplants and Cellular Therapies
    Autologous | Allogenic | Immune Effector Cells
  • Sources of Stem Cells
    Peripheral Blood | Bone Marrow | Umbilical Cord Blood
  • Recipient Suitability & Evaluation
    Eligibility Education | Caregiver Education | Donor Selection, Care and Education
  • Stem-Cell Procurement
    Mobilization | Processing Procedure | Storage of Cellular Product
  • Preparative Regimens
    Intensity of Therapy | Chemotherapy | Radiation Therapy | Biotherapy | Immunotherapy | Targeted Therapies
  • Stem-Cell Infusion
    Fresh and Cryopreserved | Infusion Management | Hematologic ABO Incompatibilities
  • Types of GVDH
    Toxicity and Grading Scales
  • Common Symptoms to Manage GVHD | Early Post-Transplant Management
    Immunosuppressive Therapy | Infection Prevention and Management of Sepsis | Hematologic | Immune Reconstitution | Nutritional Support | Acute System-Specific Complications | Graft Rejection and Failure
  • Late Post-Transplant Management and Education
    GVHD | System-Specific Late Effects | Infection Prevention | Disease Relapse | Malignancy | Follow-Up Care/Visits 
  • Quality of Life and Evaluation